Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
-
-
Executive PageEAN NewsFeatured SliderExecutive Page: Happy New Year 2021 from the EAN, the Home of Neurology
Happy New Year 2021 from the EAN, the Home of Neurology -
Paper of the MonthEAN NewsCOVID-19COVID-19 Paper of the month: Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2. -
As a Christmas Special to EAN’s RRFS members, we hosted a series of three Master Classes in the course of December 2020 for free. -
Executive Page: Welcome to new year by Editor-in-Chief -
Paper of the MonthEAN NewsFeatured SliderResearch Paper of the month: Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial
For January 2021, we have selected: M. Obermann et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol 2020, November 24, 2020. https://doi.org/10.1016/S1474-4422(20)30363-X. -
Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Prof. Marco Medina, President of the Pan American Federation of Neurological Societies (PAFNS) -
Congress Registration is open -
Abstract submission for EAN Congress 2021 is now open! -
Breaking newsEAN NewsCOVID-19ResearchMononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19 -
Breaking newsEAN NewsCOVID-19ResearchImpact of COVID-19 pandemic lockdown on narcolepsy type 1 management
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management -
Breaking newsEAN NewsCOVID-19ResearchCOVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments -
Pattern of cognitive deficits in severe COVID-19
-
European Multicenter Study of ET-COVID-19
-
COVID-19, de novo seizures, and epilepsy: a systematic review